Post-mortem cat bladder study maps distinct CB1 and CB2 patterns

Cellular Distribution and Expression of Cannabinoid Receptors Type 1 and 2 in the Urinary Bladder of Cats (Felis catus).

International journal of molecular sciences β€’ β€’ Highly Relevant
πŸ€–

AI Summary

This post-mortem study examined the expression and cellular location of CB1 and CB2 cannabinoid receptors in urinary bladder samples from 11 cats without a history of lower urinary tract disease. Using gene-expression tests, protein analysis, and tissue imaging, the researchers found CNR2 transcripts in the urothelium and detrusor muscle, while CNR1 transcripts were not detectable. Protein bands for both receptors were detected by Western blot.

The receptors showed different patterns in the bladder: CB1 staining was significantly stronger in the detrusor muscle, while CB2 staining was significantly stronger in the urothelium, particularly in umbrella cells. This is descriptive laboratory research in cats, not a treatment trial. The findings provide a basis for further investigation of the endocannabinoid system in feline bladder disorders, but cannot establish whether targeting these receptors would be safe or effective. This is an abstract-based summary; the study’s small, disease-free post-mortem sample limits conclusions about cats with urinary disease.

πŸ’‘ Key Findings

1
In bladder samples from 11 cats, CNR2 transcripts were detected in both urothelium and detrusor muscle, but CNR1 transcripts were not detectable.
High
95%
2
Protein analysis detected bands for both CB1 and CB2 receptors, despite the absence of detectable CNR1 transcripts.
High
95%
3
CB1 immunoreactivity was significantly higher in detrusor muscle, while CB2 immunoreactivity was significantly higher in urothelium.
High
95%
4
The post-mortem study involved cats without a history of lower urinary tract disease; it does not show that receptor-targeting treatments help cats with bladder disorders.
High
98%

πŸ“„ Original Abstract

This study aimed to qualitatively and quantitatively characterize the gene and protein expression of cannabinoid receptors type 1 (CB1) and 2 (CB2), and to describe their cellular distribution in the urinary bladder of cats. Samples were collected post-mortem from 11 cats with no history of lower urinary tract disease and were analyzed using reverse-transcription quantitative PCR (RT-qPCR), Western blot, and immunofluorescence. Mean fluorescence intensity was analyzed in the urothelium and detrusor muscle using a paired t-test (p < 0.05). CNR2 transcripts were detected in both compartments, whereas CNR1 transcripts were not detectable. Western blot detected both CB1 and CB2 bands. CB1R immunoreactivity (CB1R-IR) was sparse within the urothelium, with occasional umbrella and basal cells, and was detected in endothelial cells, intramural neurons, nerve fibers, and detrusor smooth muscle cells. CB1R-IR was significantly higher in the detrusor muscle (p = 0.0006). CB2R-IR showed marked staining in umbrella cells and faint staining in basal cells; it was also observed in bundles of nerve fibers, intramural neurons, detrusor smooth muscle cells, and vascular structures. CB2R-IR was significantly higher in the urothelium (p < 0.0001). These findings provide a molecular basis for studies investigating the endocannabinoid system as a potential therapeutic target in feline lower urinary tract disorders.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.